PIK3CA and breast carcinoma: Despite the challenges that remain, the rapid evolution of PIK3CA-targeted therapies, including combination approaches and the exploration of novel targets, offers significant promise in revolutionizing the treatment of breast cancers with PIK3CA alterations.